Dr. Khan is a current gastroenterology fellow at the Mayo Clinic in Rochester with a passion for liver disease. Her academic interests include hepatobiliary neoplasia, medical education and healthcare disparities.

Assistant Professor in Transplant Hepatology at The University of Michigan and Associate Program Director for the Michigan GI fellowship. Prior lead of the AASLD Liver Fellow Network.

Naim Alkhouri, MD, FAASLD, DABOM is the Chief Medical Officer at Summit Clinical Research and the Director of Research at the Clinical Research Institute of Ohio (CRIOH) in Cleveland, OH. Dr. Alkhouri is a key opinion leader in the field of MASH therapeutics and an advisor/ consultant to many pharmaceutical and biomarker development companies. He is Principal Investigator on several multicenter global MASH trials and a member of the AASLD MASLD Special Interest Group (MASLD SIG).

Christopher Sonnenday, M.D., M.H.S., is the Darrell A. Campbell, Jr, M.D., Collegiate Professor of Transplant Surgery at the University of Michigan and Transplant Center Director for University of Michigan Health. He serves as Surgical Director of Living Donor Liver Transplantation and Surgical Director of the Multidisciplinary Liver Tumor Program for Michigan Medicine. Dr. Sonnenday's clinical interests focus on liver transplantation, liver cancer, and hepatobiliary surgery.

Amanda Cheung, MD, is an Assistant Professor of Medicine at Northwestern University Feinberg School of Medicine and a transplant hepatologist at Northwestern Medicine. Board certified in internal medicine, gastroenterology, and transplant hepatology, Dr. Cheung specializes in liver disease, liver transplantation, metabolic dysfunction-associated steatotic liver disease, alcohol-associated liver disease, and Wilson disease. She serves as Director of Hepatology Clinical Trials and Co-Director of the Wilson Disease Clinic Center of Excellence at Northwestern.

Mina Rakoski MD, MSc is the Medical Director of Liver Transplant at Loma Linda University Health.

Syed-Mohammed Jafri M.D. is a Gastroenterologist and Transplant Hepatologist at Henry Ford Hospital in Detroit. He was born in Niagara Falls, NY and raised in Detroit, Michigan. His education includes Residency in Internal Medicine at The Mayo Clinic in Rochester, Gastroenterology Fellowship at the University of Texas and Transplant Fellowship at the University of Michigan.

Dr. Gene Im is a transplant hepatologist and Director of the Alcohol-associated Liver Disease Program (ADAPT) at Columbia University, NY, USA. He is founder of the annual ALD-ALLY conference and is serving as the Chair of the AASLD Alcohol SIG. His clinical and research interests are in alcohol-associated liver disease, alcohol-associated hepatitis and liver transplantation.